Skills
About
Andrew Baker-Campbell Andrew Baker-Campbell is a seasoned leader in medical technology innovation and a board member at pioneering technology development organisation TTP. He is Co-Founder and Chairperson of LEX Diagnostics, a point-of-care diagnostics company working towards regulatory approval following a successful 4,000-patient clinical trial. Andrew has led the company through key milestones - from first IP filings, to raising over $40M in strategic investment. LEX plans to launch their revolutionary 5-minute PCR test for Flu A, Flu B, and COVID-19 in winter 25/26. Andrew also leads the HealthTech division at TTP, helping some of the world’s most ambitious MedTech and Pharma companies bring game-changing products to market. His teams of engineers, scientists and designers operate at the forefront of complex, multidisciplinary innovation - spanning biosensors, surgical robotics, neuromodulation, drug delivery, ophthalmic innovation and beyond. Andrew has led teams that have delivered breakthrough technologies for global leaders including Philips, Bayer and Becton Dickinson, as well as supported high-growth start-ups bringing first-of-a-kind products to market. He is the author of several patents in sensing and microdevice technologies and brings deep expertise in technology innovation, IP generation and licensing, and business development. Andrew earned his PhD in Optoelectronics from the University of Cambridge.
Andrew Baker Campbell
Published content
expert panel
AI and digital health tools are advancing at breakneck speed, yet adoption and outcomes often lag behind investment. While hospitals and health systems race to deploy chatbots, predictive analytics and remote monitoring, many solutions remain incremental rather than transformative. A comprehensive survey published in the Journal of the American Medical Informatics Association found that while health systems are piloting or deploying a wide range of AI use cases, success and implementation depth vary dramatically across clinical and operational domains, with many tools still immature or not integrated into care delivery workflows. The result: technology that generates data but fails to meaningfully change care delivery. Members of the Senior Executive Healthcare Think Tank—a curated group of leaders spanning patient experience, workforce strategy, equity, quality, policy and health technology—see a different path forward. Drawing on deep expertise across AI, EHRs, diagnostics, telehealth and care-at-home models, they argue that the next wave of impact will come not from more dashboards, but from smarter, more adaptive and more human-centered systems. Below, they identify underrepresented areas of innovation that hold disproportionate promise for improving outcomes and reducing burden for clinicians.
Company details
TTP plc
Company bio
TTP’s HealthTech team helps visionary teams turn bold ideas into breakthrough devices, combining deep science, advanced engineering and commercial foresight to overcome the most demanding technical and system-level constraints. From concept to clinical feasibility, we bring clarity to complexity and confidence to every step forward.